Moreover, AD patients with a blood natural killer (NK) cell deficiency and a deficit of murine NK cells (IL-15−/− mice) showed enhanced AD inflammation in the skin, suggesting that an immunotherapy strategy for AD treatment could be promising [93]. The gene discussed is IL15; the disease is Alzheimer disease.